for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Catabasis Pharmaceuticals Reports Q1 Loss Per Share $0.29

May 10 (Reuters) - Catabasis Pharmaceuticals Inc:

* CATABASIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS

* Q1 LOSS PER SHARE $0.29

* Q1 EARNINGS PER SHARE VIEW $-0.20 -- THOMSON REUTERS I/B/E/S

* AS OF MARCH 31, 2018, CATABASIS HAD CASH AND CASH EQUIVALENTS OF $17.0 MILLION

* BELIEVES THAT IT HAS SUFFICIENT CASH TO FUND OPERATIONS THROUGH DECEMBER 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up